The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells-Reference-Cited by-同舟云学术

The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells

Published:2019-11-08 Issue: Volume:10 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Uzieliene Ilona,Bernotiene Eiva,Rakauskiene Greta,Denkovskij Jaroslav,Bagdonas Edvardas,Mackiewicz Zygmunt,Porvaneckas Narunas,Kvederas Giedrius,Mobasheri Ali

Funder

European Social Fund

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference36 articles.

1. Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study;Rahman;Arthritis Care Res.,2013

2. Osteoarthritis and the risk of cardiovascular disease : a meta- analysis of observational studies;Wang;Sci Rep.,2016

3. Metabolic osteoarthritis: relation of cardiovascular disease and diabetes to knee osteoarthritis;Kuusalo;Sci Rep.,2016

4. Revealed aspect of metabolic osteoarthritis;Chadha;J Orthopaed.,2016

5. Metabolic syndrome-associated osteoarthritis;Courties;Curr. Opin. Reumathol.,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database;Frontiers in Pharmacology;2024-09-02

2. The role of O-GlcNAcylation in bone metabolic diseases;Frontiers in Physiology;2024-06-10

3. A Cross-Sectional Study of Factors Predicting the Duration of the Efficacy of Viscosupplementation in Knee Osteoarthritis;Journal of Clinical Medicine;2024-03-27

4. O-linked β-N-acetylglucosaminylation may be a key regulatory factor in promoting osteogenic differentiation of bone marrow mesenchymal stromal cells;World Journal of Stem Cells;2024-03-26

5. Kidney organoid models reveal cilium-autophagy metabolic axis as a therapeutic target for PKD both in vitro and in vivo;Cell Stem Cell;2024-01